How Does Metformin Actually Work for PCOS?

Metformin works for PCOS through several overlapping mechanisms, not just one. It reduces the amount of glucose the liver releases into the bloodstream, which lowers circulating insulin levels. Because excess insulin is a key driver of the elevated androgens (“male hormones”) that cause many PCOS symptoms, bringing insulin down has a cascade of downstream benefits: lower testosterone, more regular periods, and improved ovulation. But metformin also appears to act directly on ovarian cells and may even reshape the gut microbiome. The full picture is more layered than the textbook version of “it’s an insulin sensitizer” suggests.

Why Insulin Matters So Much in PCOS

To understand what metformin is doing, you first need to understand the core metabolic problem in PCOS. Insulin resistance and excess androgens are considered the two main forces driving the condition, each reinforcing the other in a feedback loop.¹ When your cells don’t respond well to insulin, your pancreas compensates by pumping out more. That surplus insulin doesn’t just affect blood sugar. It acts on the ovaries, stimulating them to produce more androgens than they otherwise would. Lab research has shown that insulin can directly enhance androgen production from ovarian cells, and it may act together with luteinizing hormone to amplify the effect.²

Studies confirm this link clinically. In women with PCOS, those with higher testosterone levels have significantly higher insulin resistance scores, even when body weight and waist circumference are similar.³ This means insulin resistance isn’t just a side issue in PCOS. It’s a central engine powering the hormonal chaos. Metformin’s primary job is to throw a wrench into that engine.

What Metformin Does in the Liver

The liver is where metformin has its best-understood effects. Your liver constantly produces glucose through a process called gluconeogenesis, and insulin resistance ramps this up, flooding the bloodstream with sugar your body didn’t ask for. Metformin puts the brakes on this process by partially blocking a specific component of the energy-production machinery inside liver cells, known as mitochondrial complex I.⁴ This isn’t a dramatic shutdown; it’s a gentle restraint that limits how much glucose the liver dumps into your blood.⁵

Lower blood glucose means the pancreas doesn’t need to produce as much insulin to keep up. With less insulin circulating, the signal telling the ovaries to crank out androgens weakens. This is the indirect route by which metformin reduces testosterone in PCOS: it doesn’t attack the androgens themselves, it chokes off one of the main stimuli driving their production.

Direct Effects on the Ovaries

The indirect path through insulin reduction is the most cited explanation, but metformin also appears to act on the ovaries themselves. Lab studies using human ovarian theca cells (the cells primarily responsible for androgen production) have shown that metformin directly inhibits the production of androstenedione and testosterone. It does this by suppressing the expression of key enzymes involved in steroid production.⁶ A separate study confirmed that metformin inhibited androgen output from theca cells by up to 40%, with the effect becoming stronger in the presence of insulin.⁷

This matters because it means metformin isn’t entirely dependent on fixing insulin resistance to lower androgens. Even at the level of the ovary, it’s actively dampening androgen synthesis. Whether this direct ovarian effect contributes as much as the systemic insulin-lowering effect in a living person is still debated, but the evidence for it existing at all is solid.

The AMPK Pathway and the Gut

Beyond the liver and the ovaries, metformin activates a cellular energy sensor called AMPK, which acts as a kind of metabolic reset switch. In animal models of PCOS, metformin improved both reproductive and metabolic function through this pathway.⁸ AMPK activation boosts the body’s ability to use glucose for energy and reduces the liver’s glucose output, complementing the complex I mechanism described above.

A more recent finding is that metformin may activate AMPK specifically in the intestines, which alters the gut microbiome. Research in PCOS models has shown that metformin rebalances gut bacteria that become disordered in the condition.⁹ A combination study using metformin and another drug confirmed that PCOS-associated gut flora disorders improved with metformin treatment, with shifts in both the diversity and composition of gut bacteria.¹⁰ This gut connection is still being mapped out, but it adds another dimension to how metformin might improve metabolic health in PCOS beyond what happens in the liver and ovaries alone.

Menstrual Cycles and Ovulation

The practical result most people care about is whether metformin actually fixes irregular periods and helps with ovulation. The answer is yes, for many women, though not all. Multiple studies have confirmed that metformin treatment reduces androgen levels, improves insulin sensitivity, restores menstrual regularity, and can trigger ovulation.¹¹ Observational studies consistently show improvements in menstrual cyclicity with metformin therapy, though the response varies from person to person.¹²

An important caveat: metformin on its own is not as effective as clomiphene citrate (a dedicated ovulation-inducing drug) when the primary goal is triggering ovulation.¹³ Metformin is better understood as a background treatment that improves the underlying metabolic environment, making other fertility treatments more effective rather than replacing them entirely.

Metformin and Pregnancy Outcomes

For women with PCOS who are trying to conceive, metformin’s role extends into pregnancy itself. A recent meta-analysis found that women who started metformin before conception and continued it through the first trimester had higher clinical pregnancy rates and a trend toward lower miscarriage rates compared to placebo.¹⁴ Interestingly, women who stopped metformin once they became pregnant still had higher pregnancy rates but also showed a trend toward increased miscarriage, suggesting that continuing the drug through early pregnancy may be protective.

An earlier study found an even starker difference: the rate of early pregnancy loss was about 9% in the metformin group compared to 36% in controls.¹⁵ These findings are promising, but the decision to continue metformin during pregnancy should be made with a doctor, since the evidence is still evolving and individual circumstances vary.

Lowering Inflammation

PCOS is associated with chronic low-grade inflammation, reflected in elevated C-reactive protein (CRP) levels. This inflammation is linked to insulin resistance and contributes to long-term cardiovascular risk. Metformin consistently brings CRP levels down. A meta-analysis of studies in women with PCOS found a significant reduction in CRP concentrations after metformin treatment, along with a meaningful decrease in BMI.¹⁶ Individual studies have also documented drops in insulin levels and improvements in cholesterol alongside the CRP reduction.¹⁷ One study tracking CRP over six months found the reduction was especially pronounced in women who were obese.¹⁸

This anti-inflammatory effect is clinically meaningful because women with PCOS face elevated risks of cardiovascular disease and type 2 diabetes over the long term. Reducing chronic inflammation is one of the less-discussed but genuinely valuable things metformin does.

Is Metformin a Weight Loss Drug?

Many women with PCOS are prescribed metformin partly in hopes of losing weight. The evidence here is more complicated than the prescription suggests. A randomized, double-blind, placebo-controlled trial specifically looking at fat distribution found no significant differences in visceral fat or any other measure of fat distribution between metformin and placebo groups. The study concluded plainly that metformin is not a weight loss drug, though it did show beneficial effects on blood lipids.¹⁹

Where metformin does appear to help with weight is when combined with lifestyle changes. A systematic review found that lifestyle modifications plus metformin led to a modestly lower BMI and increased menstrual cycle frequency over six months compared to lifestyle changes alone or with placebo. But the combination did not improve insulin resistance markers, lipids, or blood pressure beyond what lifestyle changes achieved.²⁰ The takeaway: expect metformin to help modestly with weight management when you’re also exercising and adjusting your diet. Don’t expect it to do the heavy lifting alone.

How Metformin Compares to Birth Control Pills

Combined oral contraceptive pills (COCPs) are the other mainstay treatment for PCOS, and the two drugs do different things. A large meta-analysis comparing them found that COCPs were significantly better at lowering free androgen levels, raising sex hormone-binding globulin, and reducing total testosterone.²¹ For visible symptoms like hirsutism (excess hair growth) and acne, COCPs tend to perform better, particularly in lean women. In overweight women, the difference in hirsutism improvement was no longer significant.

Clinical trials have similarly shown that OCPs produce greater improvements in acne and hirsutism than metformin, while metformin is the better tool for insulin resistance and metabolic parameters.²² The combination of both often outperforms either alone for symptoms like acne. If your primary concerns are cosmetic symptoms, the pill may be more effective. If your concerns are metabolic health or fertility, metformin has the advantage. Many women end up using both at different points in their lives.

Pairing Metformin with Letrozole for Fertility

For women actively trying to conceive, letrozole has become a first-line ovulation induction agent, and adding metformin to letrozole appears to improve outcomes. One study found that the clinical pregnancy rate with letrozole alone was about 19%, while adding metformin pushed it to roughly 33%. The live birth rate also climbed from about 11% to 18% with the addition of metformin.²³ Another trial combining letrozole and metformin reported a total effective rate of about 94% compared to 81% for the control group, with higher ovulation and full-term delivery rates in the combination group.²⁴

In women who don’t respond to clomiphene, the combination of metformin and letrozole has also shown promise. One trial found that metformin-letrozole led to higher full-term pregnancy rates than metformin-clomiphene, likely because letrozole doesn’t have the anti-estrogenic effects on the uterine lining that clomiphene does.²⁵

Myo-inositol as an Alternative

Myo-inositol is an over-the-counter supplement that has gained popularity as a “natural” alternative to metformin for PCOS. The evidence suggests it’s a reasonable option for some women. A systematic review found that metformin and myo-inositol are comparable in their effects on hormonal and metabolic profiles, but myo-inositol had a better safety profile with fewer side effects.²⁶ A meta-analysis found no significant difference between the two for BMI, fasting insulin, fasting blood sugar, or insulin resistance scores.²⁷

That said, metformin may still have a slight edge for certain outcomes. An evidence review informing the 2023 international PCOS guidelines noted that metformin may improve waist-hip ratio and hirsutism compared to inositol, while there was likely no difference for reproductive outcomes. Myo-inositol causes fewer gastrointestinal side effects, though metformin’s GI issues are typically mild and tend to settle over time.²⁸ If you can’t tolerate metformin’s stomach side effects, myo-inositol is worth discussing with your doctor.

Why Metformin Doesn’t Work for Everyone

One of the frustrating things about metformin in PCOS is the wide variation in how well it works from person to person. Part of this may be genetic. Metformin enters cells through specific transporter proteins, and genetic variations in these transporters affect how well the drug is absorbed and utilized. A study of 150 women with PCOS found that those carrying common genetic variants in the organic cation transporter 1 gene had a reduced metabolic response to metformin. Women with the standard version of the gene saw significant drops in cholesterol and triglycerides, while those carrying two or more variant copies saw no improvement in insulin levels at all.²⁹

This helps explain why some women swear by metformin while others notice nothing after months of use. It’s not necessarily that the drug “doesn’t work” in general; it may be that specific people are genetically less responsive to it. Pharmacogenomic testing for these transporter variants isn’t routine yet, but the research suggests it probably should be.

Side Effects and Vitamin B12

The most common complaints about metformin are gastrointestinal: nausea, diarrhea, bloating, and stomach cramps. These typically peak in the first few weeks and often improve as your body adjusts, especially if you start at a low dose and increase gradually. Extended-release formulations also tend to be gentler on the stomach.

A less well-known concern is vitamin B12 depletion. Long-term metformin use is associated with lower B12 levels, and there’s evidence that B12 deficiency may actually worsen the GI symptoms people blame on metformin itself. A study of people on long-term metformin found that those with B12 deficiency were significantly more likely to have active gastrointestinal symptoms. Among people who had been on metformin for ten years or longer and had B12 deficiency, the odds of having GI symptoms were over four times higher than in other groups.³⁰ If you’ve been on metformin for a while and the stomach problems aren’t going away, getting your B12 levels checked is a reasonable step. Supplementation is cheap and can sometimes resolve symptoms that seemed permanent.

Metformin and Depression in PCOS

Depression is disproportionately common in women with PCOS, driven by a mix of hormonal disruption, metabolic stress, and the psychological burden of the condition’s visible symptoms. There’s growing evidence that metformin may help with this too, at least partly. A study of women with PCOS enrolled in a lifestyle modification program found that those taking metformin had roughly 70% lower odds of having major depression compared to women making lifestyle changes alone. After three months of metformin therapy, average depression scores dropped significantly.³¹ The study did not find a significant effect on anxiety, so the benefit appears to be more specific to depressive symptoms. Whether this is a direct neurochemical effect of metformin or an indirect result of improved metabolic health and hormone balance isn’t fully clear yet.

The Plant That Started It All

Metformin’s origins are botanical. It derives from compounds found in Galega officinalis, commonly known as French lilac or goat’s rue, a plant that had been used in folk medicine for centuries to treat symptoms we’d now recognize as diabetes. The active compounds, guanidines, were eventually refined into metformin, though the drug’s early development was delayed by toxicity problems with related guanidine derivatives and the dominance of insulin therapy.³² It took decades of clinical validation before metformin became a first-line treatment for type 2 diabetes, and its use in PCOS came even later. The fact that a medieval herbal remedy ended up being one of the most widely prescribed drugs in the world is one of pharmacology’s better stories.